Product Program year 2025 Source: CMS Open Payments

Optablate

Device Interventional Spine

PDI 07613327524475

Open in the dashboard

General payments

$985,057

3,249 payments

Research payments

$125,000

1 payment

Through program year 2025, $985,057 in general payments and $125,000 in research payments were reported against Optablate (Interventional Spine).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $441,620 1,930
2025 Research $125,000 1
2024 General $334,409 877
2023 General $204,850 382
2022 General $4,177 60

Breakdown

Who paid General payments · program years 2022–2025
  1. Stryker Corporation $985,057 3,249 payments
Top recipients General payments · program year 2025
  1. Sean Tutton Vascular & Interventional Radiology · San Diego, CA $55,387 13% · 39 payments
  2. Jad Khalil Orthopaedic Surgery · Southfield, MI $38,452 9% · 32 payments
  3. Jason Levy Vascular & Interventional Radiology · Atlanta, GA $31,606 7% · 14 payments
  4. Milan Patel Vascular & Interventional Radiology · Houston, TX $28,622 6% · 31 payments
  5. Vishal Khemlani Pain Medicine · Tualatin, OR $24,855 6% · 31 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $162,094 38% · 129 practitioners
  2. Pain Medicine Anesthesiology $63,260 15% · 116 practitioners
  3. Diagnostic Radiology Radiology $42,883 10% · 84 practitioners
  4. Orthopaedic Surgery $42,862 10% · 11 practitioners
  5. Interventional Pain Medicine Pain Medicine $20,818 5% · 87 practitioners

The top 5 of 53 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $81,481 18% · 103 recipients
  2. Texas $50,212 11% · 103 recipients
  3. Michigan $44,989 10% · 52 recipients
  4. Georgia $40,723 9% · 43 recipients
  5. Colorado $32,114 7% · 47 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,249 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record